Design Therapeutics Balance Sheet (2020-2021) | DSGN

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021
Assets
Current Assets
Cash & Equivalents 2.38M400.69M370.84M357.66M
Short-term Investments 33.71M10.65M32.00M36.06M
Cash & Current Investments 36.09M411.34M402.84M393.72M
Prepaid Assets 0.14M0.41M2.04M1.57M
Current Assets 36.23M411.75M404.88M395.29M
Non-Current Assets
Property, Plant & Equipment (Net) 0.07M0.10M0.27M1.32M
Other Non-Current Assets 0.21M
Non-Current Assets 0.28M0.10M0.27M5.06M
Assets 36.52M411.85M405.15M400.35M
Liabilities
Current Liabilities
Accounts Payables 1.40M2.03M1.58M3.29M
Payables 1.40M2.03M1.58M3.29M
Accumulated Expenses 0.93M1.67M1.82M
Other Accumulated Expenses 0.10M0.19M0.24M
Total Current Liabilities 2.33M3.71M3.40M5.50M
Non-Current Liabilities
Preferred Stock Liabilities 45.36M
Operating Leases 3.27M
Other Non-Current Liabilities 0.14M0.14M0.14M0.01M
Total Non-Current Liabilities 2.33M3.71M3.40M8.78M
Total Liabilities 2.48M3.85M3.54M8.79M
Shareholder's Equity
Common Equity -11.31M408.01M401.60M391.56M
Shareholder's Equity -11.31M408.01M401.60M391.56M
Liabilities and Shareholders Equity 36.52M411.85M405.15M400.35M
Retained Earnings -11.92M-17.44M-25.07M-36.39M
Shares Outstanding 15.69M15.78M15.89M15.96M55.04M55.11M55.22M